COMP <GO>
BWXT vs TMO // OPERATING MARGIN
BWX Technologies Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: BWXT 7
— TMO 7
▲ OPERATING MARGIN LEADER: TMO
LAST: $130.70 (-5.24%) • MKT CAP: $12.64B
operating-margins
12.60%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BWXT VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BWXT | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.90% | 41.00% | -18.10 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.60% | 9.30% | +2.30 | BWXT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.2x | 30.4x | -5.20 | BWXT | /valuation <GO> |
| Free Cash Flow Yield | 2.34% | 2.40% | -0.06 | TMO | /fcf-yield <GO> |
| Operating Margin ACTIVE | 12.60% | 17.40% | -4.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.30% | 15.10% | -4.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 18.30% | 3.90% | +14.40 | BWXT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.73% | 0.24% | +0.49 | BWXT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.63 | 4.50 | +0.13 | BWXT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.7 | 59.1 | -18.46 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.94 | +0.01 | BWXT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.3x | 36.3x | -4.00 | BWXT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.64B | $262.22B | -$249.58B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BWXT REV | TMO REV | BWXT GROSS % | TMO GROSS % | BWXT FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.20B | $44.56B | 22.9% | 44.0% | $295.3M | $6.29B |
| FY 2024 | $2.70B | $42.88B | 24.2% | 44.0% | $254.8M | $7.27B |
| FY 2023 | $2.50B | $42.86B | 44.0% | 44.0% | $251.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BWXT // BETA 0.95
TMO // BETA 0.94